Menu

Image of the Day: Glowing Larva

Researchers identified a gene in mosquitoes that moderates their susceptibility to malaria parasite infection. 

Mar 9, 2018
The Scientist Staff, The Scientist Staff

A. gambiae transgenic larva Y. DONG ET AL.Researchers reported yesterday (March 8) in PLOS Pathogens that inactivating the gene FREP1 reduced mosquitoes’ (Anopheles gambiae) susceptibility to Plasmodium, the parasite that causes malaria in humans.

When an A. gambiae mosquito consumes a Plasmodium in a blood meal, the parasite goes through a complex infection cycle as it travels to its host’s salivary gland, from where it infects humans. The Plasmodium’s ability to complete this cycle relies on the activity of several of the mosquito’s proteins. Using CRISPR-Cas9, the team from Johns Hopkins University inactivated the gene encoding fibrinogen-related protein 1 (FREP1), a target they had previously identified as being involved in the infection process. They found that knocking out the gene suppressed Plasmodium infection in mosquitoes. In their paper, the researchers write that the technique is “a potentially powerful approach” to generating infection-resistant mosquitoes.

Y. Dong et al., “CRISPR/Cas9-mediated gene knockout of Anopheles gambiae FREP1 suppresses malaria parasite infection,” PLOS Pathogens, doi:10.1371/journal.ppat.1006898, 2018.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!